{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:26:08Z","timestamp":1787761568525,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"\n Background:<\/jats:title>\n Despite recognizing the traditional coronary artery disease (CAD) risk factors, some secondary factors, such as opioid substance abuse, have to be considered. We aimed to assess the relationship between opioid consumption and emergency percutaneous coronary intervention (PCI) revascularization results, according to Thrombolysis in Myocardial Infarction (TIMI) flow and in-hospital survival outcomes in ST-elevation myocardial infarction (STEMI) patients.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n \n This case\u2013control study was conducted on 186 patients (93 patients in each group) with acute STEMI, who were referred to Chamran Heart Center, Isfahan, Iran. Opioid addiction was diagnosed by patients' records and confirmed by conducting an interview based on the Diagnostic and Statistical Manual of Mental Disorders, 4\n th<\/jats:sup>\n Edition (DSM-IV) criteria. Patients in both groups were evaluated and compared for angioplasty results based on the TIMI flow grade and in-hospital cardiovascular events and complications.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Ninety-one patients (97.84%) of each group were male, and opioid-addicted patients were younger than the non-opioid users (52.95 9.91 vs. 57.90 12.17,\n P<\/jats:italic>\n = 0.003). Among the CAD risk factors, prevalence of dyslipidemia was significantly higher in non-opioid users, whereas cigarette smoking was higher in opioid-addicted patients (\n P<\/jats:italic>\n < 0.050). There was no significant difference between the two groups regarding pre- and post-procedural myocardial infarction complications as well as mortality rate (\n P<\/jats:italic>\n > 0.050). Also, there were no significant differences between the opioid and non-opioid users regarding TIMI flow grading, and successful PCI rate based on achieving TIMI III was 60.21% versus 59.1% in opiate-dependent and non-opioid users, respectively (\n P<\/jats:italic>\n = 0.621).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Opioid addiction has no effects on post-PCI angiographic results and in-hospital survival outcomes in STEMI patients which undergoing emergency PCI.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/abr.abr_295_21","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T03:58:19Z","timestamp":1675310299000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Does Opioid Addiction Influence Clinical and Angiographic Outcomes in STEMI Patients Undergoing Emergency PCI?"],"prefix":"10.4103","volume":"12","author":[{"given":"Afshin","family":"Amirpour","sequence":"first","affiliation":[{"name":"Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Kermani-Alghoraishi","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Sattar","sequence":"additional","affiliation":[{"name":"Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Roohafza","sequence":"additional","affiliation":[{"name":"Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Shahabi","sequence":"additional","affiliation":[{"name":"Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reihaneh","family":"Zavar","sequence":"additional","affiliation":[{"name":"Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Sadeghi","sequence":"additional","affiliation":[{"name":"Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"e005375","DOI":"10.1161\/CIRCOUTCOMES.118.005375","article-title":"Mortality from ischemic heart disease","volume":"12","author":"Nowbar","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"23 Suppl 1","key":"R2-20240830","first-page":"III15","article-title":"New risk factors for atherosclerosis and patient risk assessment","volume":"109","author":"Fruchart","year":"2004","journal-title":"Circulation"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1213\/ANE.0b013e3181b76371","article-title":"Substance use among Iranian cardiac surgery patients and its effects on short-term outcome","volume":"109","author":"Azarasa","year":"2009","journal-title":"Anesth Analg"},{"key":"R5-20240830","first-page":"218","article-title":"Is opium addiction a risk factor for acute myocardial infarction?","volume":"43","author":"Sadr Bafghi","year":"2005","journal-title":"Acta Med Iran"},{"key":"R6-20240830","first-page":"53","article-title":"Comparison of short-term clinical outcome of non-st elevation versus st elevation myocardial infarction","volume":"4","author":"Sadeghian","year":"2009","journal-title":"J Tehran Univ Heart Cent"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ihj.2020.10.003","article-title":"Opium and cardiovascular health: A devil or an angel?","volume":"72","author":"Roayaei","year":"2020","journal-title":"Indian Heart J"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-244X-8-8","article-title":"A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo","volume":"8","author":"Bjornaas","year":"2008","journal-title":"BMC Psychiatry"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-511X-7-42","article-title":"Effect of opium addiction on new and traditional cardiovascular risk factors: Do duration of addiction and route of administration matter?","volume":"7","author":"Asgary","year":"2008","journal-title":"Lipids Health Dis"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00952990802122580","article-title":"Effect of opium addiction on diabetes","volume":"34","author":"Azod","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"e2502","DOI":"10.1136\/bmj.e2502","article-title":"Opium use and mortality in Golestan cohort study: Prospective cohort study of 50, 000 adults in Iran","volume":"344","author":"Khademi","year":"2012","journal-title":"BMJ"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1002\/jcp.27780","article-title":"Cardiovascular complications and related risk factors underlying opium consumption","volume":"234","author":"Ebdali","year":"2019","journal-title":"J Cell Physiol"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2004.01.072","article-title":"Coronary artery disease and opioid use","volume":"93","author":"Marmor","year":"2004","journal-title":"Am J Cardiol"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.exger.2004.03.038","article-title":"Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts","volume":"39","author":"Peart","year":"2004","journal-title":"Exp Gerontol"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13011-020-00272-8","article-title":"The effects of opium on the cardiovascular system: A review of side effects, uses, and potential mechanisms","volume":"15","author":"Nakhaee","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41572-019-0090-3","article-title":"ST-segment elevation myocardial infarction","volume":"5","author":"Vogel","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCINTERVENTIONS.109.925180","article-title":"A model for predicting mortality in acute ST-segment elevationmyocardial infarction treated with primary percutaneous coronary intervention: Results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial","volume":"3","author":"Stebbins","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"R21-20240830","first-page":"154","article-title":"Opium decreases the age at myocardial infarction and sudden cardiac death: A long-and short-term outcome evaluation","volume":"16","author":"Roohafza","year":"2013","journal-title":"Arch Iran Med"},{"key":"R22-20240830","first-page":"670","article-title":"The effect of opium addiction on arrhythmia following acute myocardial infarction","volume":"50","author":"Mirzaiepour","year":"2012","journal-title":"Acta Med Iran"},{"key":"R23-20240830","first-page":"27","article-title":"Opium addiction and severity of coronary artery disease: A case-control study","volume":"15","author":"Masoumi","year":"2010","journal-title":"J Res Med Sci"},{"key":"R24-20240830","first-page":"35","article-title":"Relation of opium addiction with the severity and extension of myocardial infarction and its related mortality","volume":"5","author":"Dehghani","year":"2013","journal-title":"Addict Health"},{"key":"R25-20240830","first-page":"585","article-title":"Evaluation of the role of opium addiction in acute myocardial infarction as a risk factor","volume":"4","author":"Khosoosi Niaki","year":"2013","journal-title":"Caspian J Intern Med"},{"key":"R26-20240830","first-page":"83","article-title":"Survey of the effect of opioid abuse on the extent of coronary artery diseases","volume":"18","author":"Rahimi Darabad","year":"2014","journal-title":"Glob J Health Sci"},{"key":"R27-20240830","first-page":"122","article-title":"Opium dependency and in-hospital outcome of acute myocardial infarction","volume":"28","author":"Javadi","year":"2014","journal-title":"Med J Islam Repub Iran"},{"key":"R28-20240830","first-page":"115","article-title":"Opium consumption and mid-term outcome of percutaneous coronary intervention in men","volume":"9","author":"Sharafi","year":"2014","journal-title":"J Tehran Heart Cent"},{"key":"R29-20240830","first-page":"115","article-title":"Opium addiction and correlation with early and six-month outcomes of presenting with ST elevation myocardial infarction treated initially with thrombolytic therapy","volume":"11","author":"Mousavi","year":"2021","journal-title":"Am J Cardiovasc Dis"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_295_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:00:31Z","timestamp":1787760031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_295_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_295_21","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2021-09-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}